DONG-A ST CO.,LTD Logo

DONG-A ST CO.,LTD

Develops, manufactures, and markets drugs, medical devices, and diagnostics.

170900 | KO

Overview

Corporate Details

ISIN(s):
KR7170900005
LEI:
Country:
South Korea
Address:
서울 동대문구 용두동 138 ~255 천호대로 64, 서울

Description

Dong-A ST CO., LTD. is a pharmaceutical company focused on the research, development, manufacturing, and marketing of ethical drugs, medical devices, and diagnostics. The company's portfolio includes proprietary new drugs such as Stillen (gastritis), Zydena (erectile dysfunction), and Motilitone (functional dyspepsia). Operating from cGMP-compliant facilities, it exports a diverse range of products, including novel drugs, generics, and biopharmaceuticals, to global markets. The company maintains a strong commitment to innovative R&D, with a pipeline featuring first-in-class therapeutic candidates for metabolic diseases, including MASH (Metabolic dysfunction-associated steatohepatitis) and obesity, which are being advanced through a dedicated global R&D base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-05 00:00
결산실적공시예고(안내공시)
Korean 4.1 KB
2025-02-05 00:00
기업설명회(IR)개최(안내공시)
Korean 6.8 KB
2025-01-23 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.2 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.0 KB
2024-12-16 00:00
기타경영사항(자율공시) (배당기준일 변경 안내)
Korean 5.3 KB
2024-12-11 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 4.5 KB
2024-12-04 00:00
최대주주등소유주식변동신고서
Korean 52.0 KB
2024-12-04 00:00
주식등의대량보유상황보고서(일반)
Korean 280.4 KB
2024-12-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-12-04 00:00
기업설명회(IR)개최(안내공시)
Korean 6.6 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.5 MB
2024-11-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-11-07 00:00
최대주주등소유주식변동신고서
Korean 75.4 KB
2024-11-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-11-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB

Automate Your Workflow. Get a real-time feed of all DONG-A ST CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONG-A ST CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONG-A ST CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Binex Co., Ltd. Logo
Biopharmaceutical firm with pharma manufacturing and biologics CDMO services.
South Korea
053030
BioAge Labs, Inc. Logo
A clinical-stage biotech developing therapies for metabolic diseases by targeting aging.
United States of America
BIOA
BioAtla, Inc. Logo
Develops antibody-based therapeutics activated within the tumor microenvironment.
United States of America
BCAB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures medical aesthetic products like H.A. fillers and skincare.
South Korea
489460
BioCardia, Inc. Logo
Develops cell-derived therapeutics for cardiovascular and pulmonary diseases.
United States of America
BCDA
Biocartis Group NV Logo
Develops and commercializes an automated molecular diagnostics platform for oncology.
Belgium
BCART
Bioceltix S.A. Logo
Develops stem cell-based medicinal products for veterinary use.
Poland
BCX
BIOCRYST PHARMACEUTICALS INC Logo
Develops novel medicines for patients with rare and serious diseases.
United States of America
BCRX
Biodexa Pharmaceuticals Plc Logo
Clinical-stage biopharma developing treatments for rare diseases, diabetes, and cancer.
United States of America
BDRX
Biofarm S.A. Logo
A pharmaceutical company that manufactures and markets medicines and dietary supplements.
Romania
BIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.